DYRKNINGSFREMGANGSMÅDE TIL OPNÅELSE OG OPRETHOLDELSE AF EN REN ELLER BERIGET POPULATION AF NEURALE PATTEDYRSTAMCELLER OG/ELLER NEURALE PROGENITORCELLER, DER IN VITRO ER TILBØJELIGE TIL AT DIFFERENTIERE IND I CELLER AF OLIGODENDROCYTCELLELINJEN

An isolated expandable human neural stem or progenitor cell wherein the cell is a progenitor cells or stem cell, maintains its capability to differentiate into neurons, astrocytes, and oligodendrocytes, maintains its ability to differentiate into oligodendrocyte lineage cells efficiently throughout...

Full description

Saved in:
Bibliographic Details
Main Author Kido, Tsuneo
Format Patent
LanguageDanish
Published 08.07.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An isolated expandable human neural stem or progenitor cell wherein the cell is a progenitor cells or stem cell, maintains its capability to differentiate into neurons, astrocytes, and oligodendrocytes, maintains its ability to differentiate into oligodendrocyte lineage cells efficiently throughout subsequent passages, and the cell expresses at least cell surface antigens CD133 and CD140α. Also provided is a method of in vitro culturing an expandable neural progenitor or stem cell isolated from a mammalian central nervous system, and the culture itself, wherein said cell maintains its capability to differentiate into neurons, astrocytes, and oligodendrocytes and its ability to differentiate into oligodendrocyte-lineage cells efficiently. In addition, a method of treating a condition caused by a loss of myelin or a loss of oligodendrocytes is provided as is a composition comprising an isolated expandable neural stem cell or one cultured by the methods of the invention.
AbstractList An isolated expandable human neural stem or progenitor cell wherein the cell is a progenitor cells or stem cell, maintains its capability to differentiate into neurons, astrocytes, and oligodendrocytes, maintains its ability to differentiate into oligodendrocyte lineage cells efficiently throughout subsequent passages, and the cell expresses at least cell surface antigens CD133 and CD140α. Also provided is a method of in vitro culturing an expandable neural progenitor or stem cell isolated from a mammalian central nervous system, and the culture itself, wherein said cell maintains its capability to differentiate into neurons, astrocytes, and oligodendrocytes and its ability to differentiate into oligodendrocyte-lineage cells efficiently. In addition, a method of treating a condition caused by a loss of myelin or a loss of oligodendrocytes is provided as is a composition comprising an isolated expandable neural stem cell or one cultured by the methods of the invention.
Author Kido, Tsuneo
Author_xml – fullname: Kido, Tsuneo
BookMark eNqNjk1OwzAQhbOABX93GPYgJCJFbN164k7rzETOFKmrqkJmhdJK5Qq9A_fJnVgzJBVrFrbfPH-j966Li37f56vi22_SiolDVydsgjPRDCePoBRBWh5OGDsECTYk1IVEPxquBmRIdjBGTDDDRAEVWmnX0SkJ_yKM6-QiQutU0ZI6dc18WpDwNIk_JklAJpU0EQ_g7ZcYXkmTgGmrNBu-lhgtaeznFDzVNVoNJbuN9kBwTrB8MVQ8sk8y3-joR-Il8m1x-b77OOa783tT3Neo88VjPuy3-XjYveU-f2796rmqyqp8US3L_zA_kN5hLg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID DK2663638TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_DK2663638TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 14:58:14 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Danish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_DK2663638TT33
Notes Application Number: DK20120701024T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190708&DB=EPODOC&CC=DK&NR=2663638T3
ParticipantIDs epo_espacenet_DK2663638TT3
PublicationCentury 2000
PublicationDate 20190708
PublicationDateYYYYMMDD 2019-07-08
PublicationDate_xml – month: 07
  year: 2019
  text: 20190708
  day: 08
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies Oligogen Inc
RelatedCompanies_xml – name: Oligogen Inc
Score 3.209416
Snippet An isolated expandable human neural stem or progenitor cell wherein the cell is a progenitor cells or stem cell, maintains its capability to differentiate into...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title DYRKNINGSFREMGANGSMÅDE TIL OPNÅELSE OG OPRETHOLDELSE AF EN REN ELLER BERIGET POPULATION AF NEURALE PATTEDYRSTAMCELLER OG/ELLER NEURALE PROGENITORCELLER, DER IN VITRO ER TILBØJELIGE TIL AT DIFFERENTIERE IND I CELLER AF OLIGODENDROCYTCELLELINJEN
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190708&DB=EPODOC&locale=&CC=DK&NR=2663638T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8IwsFE06puf8Ts1MTy5CCkMeSBmrN0obO1Si5EnssGW8AJGMf4C_oP_h__ks7cC6os-bLldr71Lu_Z6t94NoevSwE6zrJpaMSmlVsVOyhao4diq17IsJsMqqMA8wDkUdqtbaT9Vn9bQaBULY_KEvpvkiDCjBjDfp2a9fv5xYlFztvL1NhkBanLv6QYtLq1j0G610l2RNhssklS6Rddt0E5RqAboIQKvmibraAN20TVjsz0286CU598axdtFmxE0Np7uobVhvI-23dWP1_bRVrj83g3gcuq9HqBP2lMdwYX_4CkW-g4A4XxGGdY8wDIS81nuOMLShwfFdEsG1CAcDzOBFVwsCJjCTbDcfKZxJKNuYBxUOYlgXeUEDEeOhqWspx60E7qLCtK_XQDfNEr6THAt1YLiBlMo5QI_cq0kBhhEas4_2iwATkY-R2PKPY-BGJrDHagp5njJAfhLIJWUCaqk29MGH3DRZuIQXXlMuy0LOrD_PVh92ll1tSbkCBXGk3F6jPCgXB8MExITO65X4hrJk8aQrFzPCOwQ7cQ-Qad_t3P6X-EZ2skH3hyhvTtHhenLW3oBG4VpcmmG-AuAhrRl
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3Rbtow0Grp1O5tbTd1tNtcqeJpESBDgAc0hdgJBseOjKnKE0ogkfpCq0G1L-Af9j_8U593MdD2ZX1IdDlffCfb5_NdfA5CN7WZm-V5M3MSUsuchpvWHTDDidNp5XlC5k0wgUWCcyTd_rgxuGveHaD7fS6MPSf0jz0cETRqBvq-svP142sQi9q9lctqeg-oh1-B6dLKzjsG69aqtSu012Wxosqv-H6XDitSd8EOERhqhhyiI1hht62ndNsrklIe31qU4BP6EENli9UpOpgnZ-jE3_947QwdR7vv3QDuVG95jp7pRA8ll-Eo0CwKPQCizZoybLjAKpabdRE4wiqEB81MXwlqEV6AmcQaLiYE07gHnlvIDI5VPBY2QFWQSDbWnmA49gxMZRM9Ml7kb19QYXULvNBoFTLJjdJbip-YQimX-JYbrTDAIFJv83fABHCy8nkGUx4EDMQwHO5ATTHHOw7AXwGpokxSrfyJsXjB5YDJz-g6YMbvO9CA05fOmtLhvqkNIV9QafGwyC4QntU7s3lKEuImnUbSIsWhMSSvd3ICK0Q3db-i8v_rKb9X-AOd9E0kpiDV8BJ9LAaB3U7bvkKl1e-n7BssGlbpd9vd_wAh7bdV
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DYRKNINGSFREMGANGSM%C3%85DE+TIL+OPN%C3%85ELSE+OG+OPRETHOLDELSE+AF+EN+REN+ELLER+BERIGET+POPULATION+AF+NEURALE+PATTEDYRSTAMCELLER+OG%2FELLER+NEURALE+PROGENITORCELLER%2C+DER+IN+VITRO+ER+TILB%C3%98JELIGE+TIL+AT+DIFFERENTIERE+IND+I+CELLER+AF+OLIGODENDROCYTCELLELINJEN&rft.inventor=Kido%2C+Tsuneo&rft.date=2019-07-08&rft.externalDBID=T3&rft.externalDocID=DK2663638TT3